What is the induction dose of propofol (intravenous anesthetic agent)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propofol Induction Dose

For healthy adults under 55 years (ASA I-II), the induction dose is 2-2.5 mg/kg administered as incremental boluses of approximately 40 mg every 10 seconds until loss of consciousness occurs. 1

Standard Induction Dosing by Patient Population

Healthy Adults (ASA I-II, <55 years)

  • Dose: 2-2.5 mg/kg administered as approximately 40 mg every 10 seconds, titrated to clinical response 1
  • This applies to unpremedicated patients or those premedicated with oral benzodiazepines or intramuscular opioids 1
  • The corresponding effect site concentration at loss of verbal response is approximately 2.34 μg/mL 2

Elderly, Debilitated, or ASA III-IV Patients

  • Dose: 1-1.5 mg/kg administered as approximately 20 mg every 10 seconds 1
  • Critical pitfall: Rapid bolus administration must be avoided in this population, as it significantly increases the risk of hypotension, apnea, airway obstruction, and oxygen desaturation 1
  • The reduced clearance and higher blood concentrations in these patients necessitate the lower dosing 1

Pediatric Patients (3-16 years, ASA I-II)

  • Dose: 2.5-3.5 mg/kg for unpremedicated or lightly premedicated children 1
  • Younger pediatric patients within this age range require higher induction doses than older pediatric patients 1
  • Lower dosages are recommended for ASA III-IV pediatric patients 1
  • Pain on injection is a significant concern; consider pretreating small veins with lidocaine or using antecubital or larger veins 1

Neurosurgical Patients

  • Dose: 1-2 mg/kg using slower boluses of 20 mg every 10 seconds 1
  • Slower induction with careful titration to clinical responses results in reduced dosage requirements 1

Cardiac Anesthesia Patients

  • Dose reduction required due to propofol's effects on preload (decreased ventricular filling) and afterload (decreased arterial resistance) 1
  • The American Society of Anesthesiologists emphasizes careful titration in this population 1

Critical Administration Principles

Timing Between Doses

  • Allow 3-5 minutes between dose adjustments to assess clinical effects and avoid excessive drug accumulation 1
  • The onset of action is 30-45 seconds (equivalent to arm-brain circulation time) 3

Impact of Premedication

  • Opioid and benzodiazepine premedication significantly reduces propofol requirements 1
  • Morphine premedication (0.15 mg/kg) with nitrous oxide has been shown to decrease necessary propofol maintenance infusion rates compared to non-narcotic premedication 1
  • When propofol is combined with small doses of opioids and benzodiazepines, subhypnotic doses of propofol can achieve adequate anesthesia while reducing hemodynamic instability 3

Common Pitfalls and Safety Considerations

Cardiovascular Depression

  • Hypotension is the most common complication, occurring in a dose-dependent manner due to decreased cardiac output, systemic vascular resistance, and arterial pressure 3, 4
  • Have vasopressors (ephedrine or metaraminol) immediately available 5
  • Consider elevation of lower extremities when additional fluid therapy is contraindicated 5

Respiratory Depression

  • Dose-dependent respiratory depression occurs, with potential for apnea, particularly with rapid bolus administration 3
  • Continuous monitoring of heart rate, blood pressure, and pulse oximetry is mandatory 3

Contraindications

  • Avoid in patients with egg, soy, or sulfite allergies, as propofol contains 10% soybean oil and 1.2% purified egg phosphatide 3
  • Propofol is NOT contraindicated in sulfonamide allergy 3

Pain on Injection

  • Occurs in up to 30% of patients receiving intravenous bolus 3
  • This is particularly important in pediatric patients, where pretreatment with lidocaine or use of larger veins is recommended 1

References

Guideline

Propofol Pharmacology and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypertension During Propofol Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propofol Infusion in Neurosurgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.